injectable glutathione with vitamin c Glutathione IV Therapy: Detox, Brighten

Nano based drug delivery systems: Recent developments and future prospects

Explor Target Anti-Tumor Ther 1002303

Yes semaglutide (Wegovy) and liraglutide (Saxenda) are licensed GLP-1 receptor agonist medicines available through NHS specialist weight management services for eligible patients, in line with NICE TA875 and NICE TA664 respectively

THE FUTURE OF BILE ACIDBASED THERAPEUTICS Bile acid is one of the most important components that can activate or inhibit several targets to treat metabolic disorders

A double-blind randomized controlled trial demonstrated that 24 weeks of taVNS intervention improved scores on multiple cognitive measures, including the Montreal Cognitive Assessment-Basic, Auditory Verbal Learning Test, and Boston Naming Test, with only mild and reversible adverse effects, confirming its clinical safety and efficacy ( Trial (Safety and feasibility of transcutaneous vagus nerve stimulation in mild cognitive impairment) will further evaluate the safety and feasibility of taVNS in 40 participants, providing additional evidence for early intervention in AD ( In summary, current VNS research predominantly focuses on the treatment of PD